These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 9363044

  • 1. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH, Worthington JJ, Manfro GG, Otto MW, Zucker BG.
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Abecarnil, a new beta-carboline, in the treatment of anxiety disorders.
    Aufdembrinke B.
    Br J Psychiatry Suppl; 1998; (34):55-63. PubMed ID: 9829018
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Buspirone in the long-term treatment of generalized anxiety disorder.
    Feighner JP.
    J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P, Touchon J, Billardon M.
    Encephale; 1997 Dec; 23(4):290-9. PubMed ID: 9417395
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP.
    Encephale; 1995 Dec; 21(6):459-66. PubMed ID: 8674471
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder.
    Ballenger JC, McDonald S, Noyes R, Rickels K, Woods SW, Patin J, Lydiard B, Garvey M, Cook B, Goodard AW.
    Adv Biochem Psychopharmacol; 1992 Dec; 47():431-47. PubMed ID: 1354920
    [No Abstract] [Full Text] [Related]

  • 12. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Buspirone in major depression: a controlled study.
    Rickels K, Amsterdam JD, Clary C, Puzzuoli G, Schweizer E.
    J Clin Psychiatry; 1991 Jan; 52(1):34-8. PubMed ID: 1988416
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients.
    van Laar MW, Volkerts ER, van Willigenburg AP.
    J Clin Psychopharmacol; 1992 Apr; 12(2):86-95. PubMed ID: 1573045
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.